Third-line platinum-based chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma
{{output}}
Background/objective: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with limited later-line therapeutic options. This retrospective study aimed to evaluate the efficacy and safety of platinum-based chemother... ...
